Skip to content

Generate Biomedicines, Inc. GENB Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

MYR Group logo
MYR GroupMYRG
$50.36M+18.9%
Hinge Health, Inc. logo
Hinge Health, Inc.HNGE
$5.96M
Liberty Global logo
Liberty GlobalLBTYB
$772.4M+6.1%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$58.39M+5.1%
Seaboard logo
SeaboardSEB
$348M0.0%
Mirion Technologies logo
Mirion TechnologiesMIR
$30.8M+2.7%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's operating lease ROU assets?
Generate Biomedicines, Inc. (GENB) reported operating lease ROU assets of $57.77M in Q1 2026.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.